BXP
60
6
CCL
70
2
EMC
89
7
AME
60
4
CVX
32
4
EOG
46
14
EMN
42
2
BAC
57
-9
EIX
45
2
DOV
55
14
EXPE
72
3
INTC
22
-7
FITB
60
4
F
34
2
CRM
40
6
GS
62
3
EA
52
2
DGX
57
2
CTSH
52
2
FOX
44
2
BXP
60
6
CCL
70
2
EMC
89
7
AME
60
4
CVX
32
4
EOG
46
14
EMN
42
2
BAC
57
-9
EIX
45
2
DOV
55
14
EXPE
72
3
INTC
22
-7
FITB
60
4
F
34
2
CRM
40
6
GS
62
3
EA
52
2
DGX
57
2
CTSH
52
2
FOX
44
2
Financhill
Back

Ascendis Pharma AS Stock Predictions

The EXACT DAY Certain Stocks Soar - Year After Year

Find out now - completely free of charge.
Sell
43

ASND
Ascendis Pharma AS

Last Price:
$173.23
Seasonality Move:
10.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Tariffs Are Reshaping Markets

Grade any 3 stocks FREE to see if your portfolio is at risk.

Ascendis Pharma AS Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 39.6% based on the past 10 years of stock performance.
  • Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Ascendis Pharma AS Stock Undervalued?
    The current Ascendis Pharma AS [ASND] share price is $173.06. The Score for ASND is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 39.6% based on the past 10 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell
43
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

  • Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
183.00
52-Week Low:
111.09

Prediction Charts

Market Cap:
10.5B
Price in USD:
173.06
Volume:
596K
Beta:
0.59

Technical Analysis

SMA50:
159.29
SMA100:
150.88
SMA200:
142.09
52-Wk Change:
24.95%

Stock Predictions

  • Is Ascendis Pharma AS stock public?
    Yes, Ascendis Pharma AS is a publicly traded company.
  • What is the Ascendis Pharma AS stock quote today?
    The Ascendis Pharma AS stock price is 173.06 USD today.
  • How to buy Ascendis Pharma AS stock online?
    You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-19 157.00 160.33 160.38 156.46
May-20 160.34 161.57 162.22 157.70
May-21 160.38 158.10 162.38 157.02
May-22 157.97 160.05 161.79 156.10
May-23 157.77 162.00 162.12 153.49
May-27 163.55 157.27 163.55 156.83
May-28 156.71 159.24 160.30 156.56
May-29 160.06 163.57 164.82 158.16
May-30 163.50 162.84 165.67 162.70
Jun-2 165.50 175.69 177.94 165.02
Jun-3 176.34 174.40 179.40 172.60
Jun-4 173.75 173.69 177.97 168.11
Jun-5 173.64 177.55 177.83 167.55
Jun-6 175.94 173.06 178.12 171.55

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.60 per share, an increase this year of $1.96 per share, and an increase next year of $7.43 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.